ILT4 reprograms glucose metabolism to promote tumor progression in triple-negative breast cancerHaiqin Zhang(Shandong University), Yuping Sun(Shandong University)Journal of Cell ScienceAugust 25, 202310.1242/jcs.260964Cited by 5SaveCiteExport RISWatch citationsRelated PapersCLDN18.2–targeting antibody–drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial|Nature Medicine|2025|29Tumor-derived Immunoglobulin-like transcript 4 facilitates angiogenesis of colorectal cancer.|PubMed|2023|8